In summary, TEXhi tumors display an “inflamed tumor” phenotype, with upregulation of numerous IFN-γ–associated genes, increased chemokines, antigen presentation–related molecules, and antitumor immune subsets, such as M1 macrophages, NK cells, and effector CD8+ T cells. Here, CD8A is linked to neoplasm.